DnaJ heat shock protein family member C19 pseudogene 7 (DNAJC19P7)

DNAJC19P7 is annotated as a **pseudogene** related to the DNAJC19 gene, which is a member of the DnaJ heat shock protein family involved in mitochondrial function[2]. Unlike its protein-coding parent gene, DNAJC19P7 *does not encode a functional protein*[5]. Pseudogenes typically contain disabling mutations that prevent protein expression and are generally regarded as nonfunctional; however, some pseudogenes may be transcribed into RNA and potentially play regulatory roles in gene expression through noncoding RNA interactions in certain biological contexts[3][1]. There is currently **no evidence supporting DNAJC19P7 being a therapeutic target or having direct disease relevance**; it does not belong to common molecular target families such as receptors, enzymes, transporters, ion channels, or transcription factors. Thus, its assignment as a "target" is likely incorrect for drug development or biomarker purposes. Key context: - **Pseudogenes** are not considered therapeutic targets. Their primary function in the genome may be limited to regulatory effects (via noncoding RNA mechanisms), but these activities are rarely characterized or exploited in a clinical context[1][3][5]. - The designation "is_incorrect" is set to true because DNAJC19P7 is not a canonical drug target, and current databases or literature do not attribute therapeutic or direct biological functions to this locus[2]. - Its biological relevance is essentially as a **genomic relic** or possible noncoding RNA regulator, not as a coding protein or actionable target for drug discovery. If you need information about *DNAJC19*, the protein-coding gene from the same family, it may be a distinct entity with mitochondrial chaperone function, but DNAJC19P7 itself is not equivalent.